Inspire Medical Systems, Inc. Announces the Addition of Charisse Y. Sparks, M.D. as Chief Medical Officer
31 Julho 2023 - 9:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical
technology company focused on the development and commercialization
of innovative, minimally invasive solutions for patients with
obstructive sleep apnea (OSA), today announced the addition of
Charisse Y. Sparks, M.D., as Chief Medical Officer, effective July
27, 2023. As Chief Medical Officer, Dr. Sparks will be a member of
Inspire’s executive leadership team and will lead the Company’s
medical and clinical affairs functions. Dr. Sparks will report to
Tim Herbert, President and Chief Executive Officer of the Company.
“We are excited to add Dr. Sparks, a board-certified physician
with extensive business and leadership experience, to our executive
team,” said Tim Herbert, President and Chief Executive Officer of
Inspire Medical Systems. "Inspire has long-partnered with leading
ear, nose, and throat surgeons, and sleep physicians, as part of
our medical advisory boards. In her role as our Chief Medical
Officer, Dr. Sparks will continue to amplify these important
collaborations, further enhancing our focus on delivering
high-quality patient outcomes. As a result of her deep knowledge of
Inspire’s business from her service on the Board, Dr. Sparks is
well-positioned to lead Inspire’s clinical development initiatives
to ensure optimized therapy design and inclusion of critical user
inputs,” added Herbert.
Dr. Sparks received her Doctor of Medicine degree from the
University of Kansas School of Medicine, and completed her
residency in orthopaedics at the University of Arkansas for Medical
Sciences and fellowship training in orthopaedic trauma at Harvard
Medical School. She is board-certified in orthopaedics specializing
in orthopeadic trauma. She practiced as an orthopaedic trauma
surgeon for over 10 years becoming a leader in building and
implementing ACS trauma centers, specializing in delivered care and
processes.
Dr. Sparks transitioned formally into industry by joining DePuy
Synthes, Inc., the Orthopaedic Company of Johnson & Johnson,
bringing her expertise in medical affairs and her business acumen
to the development and evaluation of new and advanced technologies.
Subsequently, Dr. Sparks served as Chief Medical Officer of
AppliedVR, Inc., a privately-held company focused on virtual
reality-based treatments that address pain and other
conditions.
“Having served on the Board of Inspire, I have developed a deep
understanding of the Inspire technology and the significant
opportunity we have to impact the sleep market in the future. It is
a tremendous opportunity to contribute as a full-time member of an
excellent leadership team,” said Dr. Sparks. “I look forward to
assisting all physicians who are in service to OSA patients deliver
outstanding clinical results and contribute to Inspire’s mission of
serving the many patients with untreated OSA.”
In her capacity on the Inspire Board, she served as a member of
the Nominating and Corporate Governance Committee. In connection
with her appointment as Chief Medical Officer of the Company,
Sparks has resigned from the Board of Directors, including the
Nominating and Corporate Governance Committee, effective upon the
commencement of her employment with the Company.
About Inspire Medical Systems
Inspire is a medical technology company focused on the
development and commercialization of innovative, minimally invasive
solutions for patients with obstructive sleep apnea. Inspire’s
proprietary Inspire therapy is the first and only FDA-approved
neurostimulation technology that provides a safe and effective
treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit
www.inspiresleep.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements other than statements of historical facts are
forward-looking statements. Forward-looking statements involve
inherent risks and uncertainties, and important factors could cause
actual results to differ materially from those anticipated,
including the factors identified under the captions “Risk Factors”
and “Management's Discussion and Analysis of Financial Condition
and Results of Operations” in our Annual Report on Form 10-K for
the fiscal year ended December 31, 2022 filed with the SEC, and as
such factors may be updated from time to time in our other filings
with the SEC, which are accessible on the SEC’s website at
www.sec.gov and the Investors page of our website at
www.inspiresleep.com. Forward-looking statements speak only as of
the date they are made, and we undertake no obligation to update
them in light of new information or future events.
Investor and Media ContactEzgi YagciVice
President, Investor
Relationsezgiyagci@inspiresleep.com617-549-2443
Inspire Medical Systems (NYSE:INSP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Inspire Medical Systems (NYSE:INSP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024